BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8747398)

  • 1. Pathology of ovarian cancer precursors.
    Scully RE
    J Cell Biochem Suppl; 1995; 23():208-18. PubMed ID: 8747398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precursor lesions of ovarian epithelial malignancy.
    Feeley KM; Wells M
    Histopathology; 2001 Feb; 38(2):87-95. PubMed ID: 11207821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability.
    Okamura H; Katabuchi H
    Ital J Anat Embryol; 2001; 106(2 Suppl 2):263-76. PubMed ID: 11732586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
    Banet N; Kurman RJ
    Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early form of ovarian cancer originating in inclusion cysts. A case report.
    Aoki Y; Kawada N; Tanaka K
    J Reprod Med; 2000 Feb; 45(2):159-61. PubMed ID: 10710752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts.
    Okamoto S; Okamoto A; Nikaido T; Saito M; Takao M; Yanaihara N; Takakura S; Ochiai K; Tanaka T
    Oncol Rep; 2009 May; 21(5):1209-14. PubMed ID: 19360296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
    Körner M; Burckhardt E; Mazzucchelli L
    J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study.
    DastranjTabrizi A; MostafaGharabaghi P; SheikhzadehHesari F; Sadeghi L; Zamanvandi S; Sarbakhsh P; Ghojazadeh M
    Diagn Pathol; 2016 Mar; 11():30. PubMed ID: 27000861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer?
    Tan OL; Hurst PR; Fleming JS
    J Pathol; 2005 Mar; 205(4):483-90. PubMed ID: 15685692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.
    Piek JM; Verheijen RH; Menko FH; Jongsma AP; Weegenaar J; Gille JJ; Pals G; Kenemans P; van Diest PJ
    Histopathology; 2003 Jul; 43(1):26-32. PubMed ID: 12823709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic precursors of ovarian epithelial tumors.
    Resta L; Russo S; Colucci GA; Prat J
    Obstet Gynecol; 1993 Aug; 82(2):181-6. PubMed ID: 8336861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preneoplastic changes in ovarian tissues.
    Brewer MA; Ranger-Moore J; Greene MH; Alberts DS; Liu Y; Bartels HG; Baruch AC; Bartels PH
    Anal Quant Cytol Histol; 2004 Aug; 26(4):207-16. PubMed ID: 15457673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 protein expression in putative precursor lesions of epithelial ovarian cancer.
    Hutson R; Ramsdale J; Wells M
    Histopathology; 1995 Oct; 27(4):367-71. PubMed ID: 8847068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors.
    Gaytan F; Morales C; Barreiro ML; Jeffery P; Chopin LK; Herington AC; Casanueva FF; Aguilar E; Dieguez C; Tena-Sempere M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1798-804. PubMed ID: 15585554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy.
    Park KJ; Patel P; Linkov I; Jotwani A; Kauff N; Pike MC
    Histopathology; 2018 Apr; 72(5):766-776. PubMed ID: 29197096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
    Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
    Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursors and pathogenesis of ovarian carcinoma.
    Lim D; Oliva E
    Pathology; 2013 Apr; 45(3):229-42. PubMed ID: 23478230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
    Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
    J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions.
    Mittal KR; Zeleniuch-Jacquotte A; Cooper JL; Demopoulos RI
    Int J Gynecol Pathol; 1993 Jan; 12(1):59-63. PubMed ID: 8418079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.